BTMD — biote Corp

biote Corp (BTMD) is a medical care facilities company listed on NASDAQ. It is led by Bret Christensen, based in 1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038, with about 223 employees. biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Latest reported BTMD revenue for 2025-09-30 was $48.0M. Net income was $9.2M. Revenue was down 1.9% from 2025-06-30 to 2025-09-30. BTMD currently screens at market cap $80.7M and trailing P/E 5.3.

Use this BTMD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BTMD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BTMD SEC filings page. Lician reads the product cache first so this HTML stays unique to biote Corp even when a live quote feed is slow.